Cover Image
市場調查報告書

靜脈瘤治療市場分析:治療形態 (硬化療法、靜脈內切除、汽提、雷射、射頻消融術) 、市場區隔的預測

Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation, Stripping, Laser, Radiofrequency Ablation), And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 368015
出版日期 內容資訊 英文 83 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
靜脈瘤治療市場分析:治療形態 (硬化療法、靜脈內切除、汽提、雷射、射頻消融術) 、市場區隔的預測 Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation, Stripping, Laser, Radiofrequency Ablation), And Segment Forecasts To 2024
出版日期: 2016年07月25日 內容資訊: 英文 83 Pages
簡介

全球靜脈瘤治療的市場規模,預計至2024年達到4億7,500萬美元。

本報告提供全球靜脈瘤治療市場相關調查,產業預測,以及治療的各類型,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 靜脈瘤治療的展望

  • 靜脈瘤治療的區分
  • 靜脈瘤治療規模、成長展望
  • 靜脈瘤治療:市場動態
    • 市場成長的促進要素分析
    • 市場阻礙成長要素分析
  • 主要的機會的優先順序
  • 產業分析:波特的五力分析
  • 靜脈瘤治療的競爭情形
    • 競爭情形:市場定位分析 (產品,地區存在感,策略倡議)
  • 靜脈瘤治療的PESTEL分析
  • 靜脈瘤治療:未來展望

第4章 靜脈瘤治療類型的展望

  • 靜脈瘤治療的佔有率:各類型
  • 硬化療法
    • 市場估計
    • 市場預測
  • 靜脈內切除
  • 汽提

第5章 靜脈瘤治療的地區展望

  • 北美
    • 市場估計:各類型
    • 市場預測:各類型
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第6章 競爭情形

  • Medtronic plc
    • 企業概要
    • 財務成果
    • 產品基準
    • 策略倡議
  • Angio Dynamics, Inc.
  • Biolitec AG
  • Syneron Medical Ltd.
  • Lumenis Ltd.
  • Dornier MedTech GmbH
  • Energist Group
  • Eufoton S. R.L.
  • Vascular Solutions, Inc.
  • Quanta Systems S.p.A.

圖表

目錄

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market.

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market.

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.

Further key findings from the report suggest:

In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.

The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.

In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.

In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region

As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.

The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income

Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.

AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.

In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.

In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope &assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Varicose Vein Treatment- Industry snapshot and key buying criteria, 2013 - 2024

Chapter 3. Varicose vein treatment Outlook

  • 3.1. Varicose vein treatment segmentation
  • 3.2. Varicose vein treatment size and growth prospects, 2013 - 2024
  • 3.3. Varicose vein treatment: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Shift towards less-invasive treatment procedures
      • 3.3.1.2. Advanced Varicose vein treatment devices
      • 3.3.1.3. Growth in ageing population
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Risk factors pertaining to varicose vein treatment
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Varicose vein treatment competitive landscape
    • 3.6.1. Competitive landscape: Market position analysis (based on products, regional presence, and strategic initiatives)
  • 3.7. Varicose vein treatment PESTEL analysis, 2015
  • 3.8. Varicose Vein Treatment: Future aspects

Chapter 4. Varicose Vein TypeOutlook

  • 4.1. Varicose vein treatment share by type, 2013 & 2024
  • 4.2. Sclerotherapy
    • 4.2.1. Sclerotherapy market estimates, 2013 - 2015 (USD Million)
    • 4.2.2. Sclerotherapy market forecasts, 2016 - 2024 (USD million)
  • 4.3. Endovenous ablation
    • 4.3.1. Endovenous ablation market estimates, 2013 - 2015 (USD Million)
    • 4.3.2. Endovenous ablation market forecasts, 2016 - 2024 (USD Million)
      • 4.3.2.1. Radio frequency ablation market estimates, 2013 - 2015 (USD Million)
      • 4.3.2.2. Radio frequency ablation market forecasts, 2016 - 2024 (USD Million)
      • 4.3.2.3. Laser ablation market estimates, 2013 - 2015 (USD Million)
      • 4.3.2.4. Laser ablation market estimates, 2013 - 2015 (USD Million)
  • 4.4. Stripping
    • 4.4.1. Stripping market estimates, 2013 - 2015 (USD Million)
    • 4.4.2. Stripping market forecasts, 2016 - 2024 (USD million)

Chapter 5. Varicose vein treatment RegionalOutlook

  • 5.1. North America
    • 5.1.1. Varicose vein treatment market estimates, by type 2013 - 2015 (USD Million)
    • 5.1.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.1.2.1. U.S.
      • 5.1.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.1.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.1.2.2. Canada
      • 5.1.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.1.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.2. Europe
    • 5.2.1. Varicose vein treatment market estimates, by type, 2013 - 2015 (USD Million)
    • 5.2.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.2.2.1. UK
      • 5.2.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.2.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.2.2.2. Germany
      • 5.2.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.2.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.2.2.3. France
      • 5.2.2.3.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.2.2.3.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.3. Asia Pacific
    • 5.3.1. Varicose vein treatment market estimates, by type 2013 - 2015 (USD Million)
    • 5.3.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.3.2.1. India
      • 5.3.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.3.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.3.2.2. China
      • 5.3.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.3.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.3.2.3. Japan
      • 5.3.2.3.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.3.2.3.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.4. Latin America
    • 5.4.1. Varicose vein treatment market estimates, by type, 2013 - 2015 (USD Million)
    • 5.4.2. Varicose vein treatment forecasts, by type, 2016 - 2024 (USD Million)
      • 5.4.2.1. Mexico
      • 5.4.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.4.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.4.2.2. Brazil
      • 5.4.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.4.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.5. MEA
    • 5.5.1. Varicose vein treatment market estimates, by type, 2013-2015 (USD Million)
    • 5.5.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.5.2.1. South Africa
      • 5.5.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.5.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)

Chapter 6. CompetitiveLandscape

  • 6.1. Medtronic plc
    • 6.1.1. Company Overview
    • 6.1.2. Financial Performance
    • 6.1.3. Product Benchmarking
    • 6.1.4. Strategic Initiatives
  • 6.2. Angio Dynamics, Inc.
    • 6.2.1. Company Overview
    • 6.2.2. Financial Performance
    • 6.2.3. Product Benchmarking
    • 6.2.4. Strategic Initiatives
  • 6.3. Biolitec AG
    • 6.3.1. Company Overview
    • 6.3.2. Financial Performance
    • 6.3.3. Product Benchmarking
    • 6.3.4. Strategic Initiatives
  • 6.4. Syneron Medical Ltd.
    • 6.4.1. Company Overview
    • 6.4.2. Financial Performance
    • 6.4.3. Product Benchmarking
    • 6.4.4. Strategic Initiatives
  • 6.5. Lumenis Ltd.
    • 6.5.1. Company Overview
    • 6.5.2. Financial Performance
    • 6.5.3. Product Benchmarking
    • 6.5.4. Strategic Initiatives
  • 6.6. Dornier MedTech GmbH
    • 6.6.1. Company Overview
    • 6.6.2. Financial Performance
    • 6.6.3. Product Benchmarking
    • 6.6.4. Strategic Initiatives
  • 6.7. Energist Group
    • 6.7.1. Company Overview
    • 6.7.2. Financial Performance
    • 6.7.3. Product Benchmarking
    • 6.7.4. Strategic Initiatives
  • 6.8. Eufoton S. R.L.
    • 6.8.1. Company Overview
    • 6.8.2. Financial Performance
    • 6.8.3. Product Benchmarking
    • 6.8.4. Strategic Initiatives
  • 6.9. Vascular Solutions, Inc.
    • 6.9.1. Company Overview
    • 6.9.2. Financial Performance
    • 6.9.3. Product Benchmarking
    • 6.9.4. Strategic Initiatives
  • 6.10. Quanta Systems S.p.A.
    • 6.10.1. Company Overview
    • 6.10.2. Financial Performance
    • 6.10.3. Product Benchmarking
    • 6.10.4. Strategic Initiatives

List of Tables

  • TABLE 1: Varicose vein treatment Market - Industry Snapshot &Key Buying Criteria, 2012 - 2022
  • TABLE 2: Global Varicose vein treatment market, by region, 2013 - 2024 (USD Million)
  • TABLE 3: Global Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 6: Varicose vein treatment - Key market driver analysis
  • TABLE 7: Varicose vein treatment - Key market restraint analysis
  • TABLE 8: North America Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 9: North America Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 1: U.S. Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 1: Canada Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 12: Europe Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 13: Europe Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 14: UK Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 15: Germany Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 16: France Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 17: Asia Pacific Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 18: AsiaPacific Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 19: Japan Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 20: China Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 21: India Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 22: Latin America Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 23: Latin America Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 24: Brazil Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 25: Mexico Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 26: MEA Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 27: MEA Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 28: South Africa Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
Back to Top